Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 4:17 PM
Ignite Modification Date:
2025-12-25 @ 2:14 PM
NCT ID:
NCT02077166
Group ID:
EG000
Title:
Phase 1b: Enrolled at Lenalidomide Dose 15 mg (Dose Level 1)
Description:
Ibrutinib 560 mg administered PO QD beginning Cycle 1 Day 1 until disease progression or unacceptable toxicity. Lenalidomide 15 mg administered PO QD on Days 1-21 of each 28-day cycle until disease progression or unacceptable toxicity. Rituximab 375 mg/m\^2 administered IV on Day 1 of each 28-day cycle for 6 cycles.
Deaths Number Affected:
7
Deaths Number At Risk:
None
Serious Number Affected:
4
Serious Number At Risk:
12
Other Number Affected:
12
Other Number At Risk:
12
Study:
NCT02077166
Results Section:
NCT02077166
Adverse Events Module:
NCT02077166